Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dipyridamole cardiac imaging.

A S Iskandrian1, J Heo, A Askenase

  • 1Philadelphia Heart Institute, Presbyterian-University of Pennsylvania Hospital.

American Heart Journal
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Journal of Nuclear Cardiology Nuclear Cardiology News Update.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2016
Same author

Journal of Nuclear Cardiology Nuclear Cardiology News Update.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2016
Same author

Journal of Nuclear Cardiology Nuclear Cardiology News Update.

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology·2016
Same author

Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia.

Vascular medicine (London, England)·2001
Same author

Heart failure: clinical implications of systolic and diastolic dysfunction.

Geriatrics·1999
Same author

Procedure guideline for myocardial perfusion imaging. Society of Nuclear Medicine.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·1998
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Dipyridamole cardiac imaging offers a valuable alternative for evaluating ischemic heart disease, comparable to exercise stress tests. This technique effectively diagnoses coronary artery disease and aids in patient risk stratification.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Diagnostic Imaging

Background:

  • Dipyridamole cardiac imaging serves as a crucial alternative to exercise stress testing for patients with ischemic heart disease.
  • Both intravenous and oral formulations of dipyridamole are utilized, with oral dipyridamole being widely accessible.

Purpose of the Study:

  • To evaluate the efficacy of dipyridamole cardiac imaging in diagnosing coronary artery disease.
  • To assess dipyridamole's role in risk stratification for patients with known or suspected heart disease.

Main Methods:

  • Utilized dipyridamole (intravenous or oral) to induce pharmacologic stress, followed by thallium-201 imaging or two-dimensional echocardiography.
  • Administered optimal doses: 0.56 mg/kg intravenous or 300-400 mg oral dipyridamole.

Related Experiment Videos

  • Analyzed thallium images for perfusion abnormalities and echocardiograms for wall motion abnormalities.

    • Main Results:

    • Dipyridamole increases coronary blood flow, leading to enhanced thallium uptake and improved image quality compared to exercise.
    • Sensitivity and specificity of dipyridamole thallium imaging are comparable to exercise thallium imaging.
    • Dipyridamole echocardiography provides high-quality studies and identifies wall motion abnormalities indicative of coronary artery disease.

    Conclusions:

    • Dipyridamole cardiac imaging is an effective diagnostic tool for coronary artery disease.
    • The technique is valuable for risk stratification, particularly in post-myocardial infarction patients and those undergoing vascular surgery.
    • Dipyridamole-induced perfusion abnormalities identify high-risk patients for future cardiac events.